Literature DB >> 24173383

Making connections: using networks to stratify human tumors.

Benjamin J Raphael1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24173383     DOI： 10.1038/nmeth.2704

Source DB:  PubMed          Journal:  Nat Methods        ISSN： 1548-7091            Impact factor:   28.547


× No keyword cloud information.
  11 in total

1.  Statistical analysis of pathogenicity of somatic mutations in cancer.

Authors:  Chris Greenman; Richard Wooster; P Andrew Futreal; Michael R Stratton; Douglas F Easton
Journal:  Genetics       Date:  2006-06-18       Impact factor: 4.562

2.  Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer.

Authors:  Liat Ein-Dor; Or Zuk; Eytan Domany
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

Review 3.  Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?

Authors:  Christos Sotiriou; Martine J Piccart
Journal:  Nat Rev Cancer       Date:  2007-07       Impact factor: 60.716

4.  Inhibition of FGFR2 and FGFR1 increases cisplatin sensitivity in ovarian cancer.

Authors:  Claire Cole; Sin Lau; Alison Backen; Andrew Clamp; Graham Rushton; Caroline Dive; Cassandra Hodgkinson; Rhona McVey; Henry Kitchener; Gordon C Jayson
Journal:  Cancer Biol Ther       Date:  2010-09-04       Impact factor: 4.742

5.  Algorithms for detecting significantly mutated pathways in cancer.

Authors:  Fabio Vandin; Eli Upfal; Benjamin J Raphael
Journal:  J Comput Biol       Date:  2011-03       Impact factor: 1.479

Review 6.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

7.  Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation.

Authors:  Cristian Tomasetti; Bert Vogelstein; Giovanni Parmigiani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

8.  Most random gene expression signatures are significantly associated with breast cancer outcome.

Authors:  David Venet; Jacques E Dumont; Vincent Detours
Journal:  PLoS Comput Biol       Date:  2011-10-20       Impact factor: 4.475

9.  Network-based stratification of tumor mutations.

Authors:  Matan Hofree; John P Shen; Hannah Carter; Andrew Gross; Trey Ideker
Journal:  Nat Methods       Date:  2013-09-15       Impact factor: 28.547

10.  Mutational heterogeneity in cancer and the search for new cancer-associated genes.

Authors:  Michael S Lawrence; Petar Stojanov; Paz Polak; Gregory V Kryukov; Kristian Cibulskis; Andrey Sivachenko; Scott L Carter; Chip Stewart; Craig H Mermel; Steven A Roberts; Adam Kiezun; Peter S Hammerman; Aaron McKenna; Yotam Drier; Lihua Zou; Alex H Ramos; Trevor J Pugh; Nicolas Stransky; Elena Helman; Jaegil Kim; Carrie Sougnez; Lauren Ambrogio; Elizabeth Nickerson; Erica Shefler; Maria L Cortés; Daniel Auclair; Gordon Saksena; Douglas Voet; Michael Noble; Daniel DiCara; Pei Lin; Lee Lichtenstein; David I Heiman; Timothy Fennell; Marcin Imielinski; Bryan Hernandez; Eran Hodis; Sylvan Baca; Austin M Dulak; Jens Lohr; Dan-Avi Landau; Catherine J Wu; Jorge Melendez-Zajgla; Alfredo Hidalgo-Miranda; Amnon Koren; Steven A McCarroll; Jaume Mora; Brian Crompton; Robert Onofrio; Melissa Parkin; Wendy Winckler; Kristin Ardlie; Stacey B Gabriel; Charles W M Roberts; Jaclyn A Biegel; Kimberly Stegmaier; Adam J Bass; Levi A Garraway; Matthew Meyerson; Todd R Golub; Dmitry A Gordenin; Shamil Sunyaev; Eric S Lander; Gad Getz
Journal:  Nature       Date:  2013-06-16       Impact factor: 49.962
View more
  3 in total

1.  Diffusion of information throughout the host interactome reveals gene expression variations in network proximity to target proteins of hepatitis C virus.

Authors:  Ettore Mosca; Roberta Alfieri; Luciano Milanesi
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

2.  Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.

Authors:  Angelo Gámez-Pozo; Lucía Trilla-Fuertes; Guillermo Prado-Vázquez; Cristina Chiva; Rocío López-Vacas; Paolo Nanni; Julia Berges-Soria; Jonas Grossmann; Mariana Díaz-Almirón; Eva Ciruelos; Eduard Sabidó; Enrique Espinosa; Juan Ángel Fresno Vara
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

Review 3.  Artificial intelligence, molecular subtyping, biomarkers, and precision oncology.

Authors:  John Paul Shen
Journal:  Emerg Top Life Sci       Date:  2021-12-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.